Mabpharm Limited's total assets for Q4 2025 were ¥1.15B, an increase of 8.06% from the previous quarter. HK:2181 total liabilities were ¥996.58M for the fiscal quarter, a 2.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.